What happens at week 5 on Wegovy

Step 1: Where week 5 sits in the Wegovy titration sequence

The Wegovy schedule is built around slow, steady escalation. You start at 0.25 mg for the first four weeks (a dose designed to let your body adjust rather than to drive weight loss) then move to 0.5 mg for weeks five through eight. Week 5 is, in that sense, the beginning of the first genuinely active phase. The 0.25 mg pen is an adjustment period; 0.5 mg is where clinical work begins.

The full titration continues upward every four weeks: 1.0 mg, then 1.7 mg, and finally the 2.4 mg maintenance dose. The full week-by-week Wegovy guide covers each of these stages in detail. For now, week 5 means your system has had a month to settle, and your prescriber has introduced the next increment.

A note worth keeping in mind: the titration exists specifically to reduce side effects, not to slow results. Moving through it too quickly (or skipping steps) raises the chance of nausea and other GI symptoms without meaningfully speeding up weight loss. Your prescriber sets the pace for a reason.

Step 2: What your body is doing in week 5, and what you might notice

Semaglutide works by activating GLP-1 receptors involved in appetite signalling and gastric emptying. By week 5, those effects are building. Many people report that food feels less urgent — portions that once felt normal start to feel like too much, and the pull toward snacking between meals quietens. That said, results at this early stage are rarely dramatic on the scales. The STEP 1 trial, published in the New England Journal of Medicine, recorded around 15% average weight reduction over 68 weeks at 2.4 mg, a figure built up gradually over many months, not concentrated in the first few.

Side effects are common at week 5 and are worth expecting rather than worrying about. Nausea is the most frequently reported, followed by loose stools, constipation, indigestion and fatigue. These typically peak in the first few days after a dose increase, then ease. If they are severe or persistent, your prescriber needs to know. You can read more about what the very first week on Wegovy feels like for comparison.

One thing our prescribers hear most weeks from patients at this stage: people are surprised that appetite changes feel almost psychological at first, a quiet disinclination rather than a loud signal to stop eating. That is normal, and it tends to become clearer over the following weeks.

Step 3: Managing week 5 day to day

Practical steps make a real difference here. Eating slowly and stopping at the first sign of fullness reduces nausea substantially. Small, protein-rich meals spread across the day tend to work better than two or three large ones. Staying well hydrated matters more than usual because GI side effects can cause fluid loss. Alcohol often feels less appealing on semaglutide, and reducing it helps the liver manage treatment more comfortably.

Sleep and light activity both support the process. Neither is a strict requirement, but both help the body regulate blood sugar and appetite in the same direction the medicine is working. For a broader picture of how semaglutide works as a medicine, that page covers the pharmacology in plain terms.

Keep a simple symptom note (even a few words in your phone) so that if you speak to your prescriber, you have something concrete to share. Cost and access questions at any point can be explored on the how to get Wegovy page.

Step 4: When to contact your prescriber rather than waiting it out

Most week-5 discomfort is mild and self-limiting. But some symptoms warrant prompt medical attention. Severe or persistent abdominal pain (particularly pain that spreads toward the back, with or without vomiting) can be a sign of pancreatitis, which the MHRA highlighted as an infrequent but serious risk in its January 2026 Drug Safety Update on GLP-1 medicines. Do not wait to see if it resolves; seek help the same day.

Other symptoms worth escalating rather than managing at home: signs of dehydration from repeated vomiting or diarrhoea, a significant allergic reaction (swelling, rash, difficulty breathing), or any low mood or thoughts of self-harm that feel new or worsening since starting treatment. The MHRA Yellow Card scheme allows patients to report suspected side effects directly, which helps build the safety picture for everyone using these medicines.

Week 6 brings another week on 0.5 mg before week 9 marks the start of the 1.0 mg phase. You can look ahead at what week 6 typically brings or skip forward to understand what changes around week 9. Each stage builds on the last. If you are considering starting Wegovy and want a prescriber to assess whether it is clinically suitable for you, starting a free consultation is the first step.